CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.590
+0.010 (0.39%)
Oct 6, 2026, 12:29 PM EDT - Market open
CytomX Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +363.32% | Sep 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $11 | Buy | Maintains | $11 | +324.71% | Aug 17, 2026 |
| Barclays | Barclays | Buy Maintains $16 | Buy | Maintains | $16 | +517.76% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +440.54% | Aug 7, 2026 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +324.71% | Jun 4, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $6 | Buy | Initiates | $6 | +131.66% | May 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $17 → $11 | Buy | Maintains | $17 → $11 | +324.71% | May 11, 2026 |